Track the 대성미생물 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 대성미생물 has logged 19 insider filings. Market capitalisation: €24.7bn. The latest transaction was disclosed on 4 June 2026 (Purchase). Among the most active insiders: 최승훈. All data is accessible without an account.
19
Insider Decl.
0
Thresholds
€17m
12 ops.
Buy Volume
€7m
1 ops.
Sell Volume
31Σ signal
Buys €17m€7m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,727 of 25,443 companies
41.6
score / 100
Value
53
Quality
30
FCF yld4.7%
Earn yld2.6%
EV/EBITDA12.2x
ROE1.9%
Gross mgn25%
Net mgn2.3%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.